Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S ( (DE:2TZ) ).
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited has announced a proposal to purchase liability insurance for the company and its directors, supervisors, and senior management. This move is aimed at enhancing corporate governance and risk management, supporting sustainable development, and protecting the rights and interests of the company and its shareholders. The insurance plan, which includes a liability limit of up to RMB100 million and an annual premium of RMB250,000, is subject to shareholder approval at an upcoming general meeting.
More about Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited, is a company incorporated in the People’s Republic of China. It operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products.
Learn more about 2TZ stock on TipRanks’ Stock Analysis page.